Ionis Pharmaceuticals Inc...

NASDAQ: IONS · Real-Time Price · USD
43.76
0.91 (2.12%)
At close: Aug 15, 2025, 3:59 PM
43.97
0.49%
After-hours: Aug 15, 2025, 07:55 PM EDT

Ionis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-458.03M -453.9M -358.81M -365.74M -384.77M -366.29M -409.45M -309.04M -328.88M -269.72M 7.32M -28.15M -3.89M -28.6M -594.64M -555.26M -518.15M
Depreciation & Amortization
4.83B 20.11M 20.46M 22.43M 22.54M 22.5M 23.91M 23.42M 22.82M 22.11M 20.06M 19.67M 19.6M 19.56M 19.14M 18.89M 17.9M
Stock-Based Compensation
128.58M 130.2M 120.39M 114.37M 110.2M 105.81M 105.16M 103.04M 100.98M 100.26M 96.83M 103.53M 109.05M 120.68M 193.46M 208.77M 227.19M
Other Working Capital
-24.14M -77.89M -110.17M -134.36M -67.61M -1.32M 42.16M -82.6M -45.63M -32.65M -31.71M -33.77M -93.03M -110.03M -69.49M -59.63M -67.12M
Other Non-Cash Items
-4.94B -135.98M -141.61M 12.12M 14.48M 25.87M -126.28M -127.42M -127.95M -134.59M 17.95M 16.73M 12.73M 7.67M 13.9M 25.48M 26.34M
Deferred Income Tax
n/a n/a -5.35M 1.08M -18.15M -18.15M -12.79M -19.23M n/a n/a 4.1M 8.73M 21.3M 25.31M 337.96M 332.36M 320.72M
Change in Working Capital
-57.04M -61.38M 12.99M -130.24M -67.78M -77.26M -121.12M -126.75M -43.67M 7.57M -16.75M -22.15M -104.98M -113.82M -44.73M -59.92M -85.18M
Operating Cash Flow
-501.78M -500.95M -351.94M -345.98M -323.46M -307.51M -540.57M -455.98M -376.71M -274.37M 129.51M 98.37M 53.81M 30.8M -74.91M -29.69M -11.19M
Capital Expenditures
-67.39M -60.54M -34.23M -28.41M -21.22M -27.22M -33.04M -36.86M -28.29M -20.1M -19.08M -16.62M -18.43M -17.9M -20.79M -29.16M -34.06M
Cash Acquisitions
n/a n/a 26.76M 27.86M 28.92M 30.18M 257.5M 434.79M 433.69M 1.26B 1.01B 828.73M 830.72M 5.95M 6.18M 6.09M 6.25M
Purchase of Investments
-1.64B -1.85B -1.94B -1.64B -1.6B -1.77B -1.62B -1.75B -1.71B -1.49B -1.42B -1.05B -1.26B -1.13B -1.13B -1.33B -1.36B
Sales Maturities Of Investments
1.66B 1.77B 1.73B 1.85B 1.81B 1.58B 1.42B 1.31B 1.18B 989.15M 1.06B 996.7M 1.11B 1.34B 1.44B 1.63B 1.84B
Other Investing Acitivies
9.55M 10.2M -14.78M -28.63M -29.69M -30.95M -3.41M -180.7M -179.61M -1B -1.01B -828.73M -830.72M -5.95M -6.18M -6.09M -6.25M
Investing Cash Flow
-39.67M -134.03M -228.95M 180.55M 187.62M -214.13M 24.73M -227.91M -300.73M -262.64M -379.67M -73.77M -171.5M 194.91M 287.65M 267.62M 448.34M
Debt Repayment
-44.67M -44.67M -164K -67.95M 86.9M 86.9M 36.34M 104.08M -50.73M -50.69M 90.09M 90.18M 90.18M 90.18M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 31.84M 18.18M 507.74M 506.98M 474.5M 487.76M -10.98M -147.28M -147.1M 165.96M 159.8M -247.21M -248.8M -561.83M
Financial Cash Flow
456.69M 478.06M 562.9M 34.58M 175.56M 644.08M 552.34M 586.44M 444.12M -55.3M -66.77M -67.14M 246.19M 245.93M -213.06M -203.58M -509.69M
Net Cash Flow
-84.7M -157.19M -17.45M -130.8M 39.86M 122.79M 37.07M -97.13M -233.48M -592.72M -317.96M -43.2M 128.36M 471.53M -106K 34.94M -72.04M
Free Cash Flow
-569.17M -561.49M -386.17M -374.39M -344.68M -334.73M -573.62M -492.84M -405M -294.47M 110.43M 81.75M 35.38M 12.9M -95.7M -58.85M -45.25M